These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35477670)

  • 1. Public health impact of covid-19 vaccines in the US: observational study.
    Suthar AB; Wang J; Seffren V; Wiegand RE; Griffing S; Zell E
    BMJ; 2022 Apr; 377():e069317. PubMed ID: 35477670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of SARS-CoV-2 vaccines on Covid-19 incidence and mortality in the United States.
    Fang F; Clemens JD; Zhang ZF; Brewer TF
    PLoS One; 2024; 19(4):e0301830. PubMed ID: 38656933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Increase in Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - Mesa County, Colorado, April-June 2021.
    Herlihy R; Bamberg W; Burakoff A; Alden N; Severson R; Bush E; Kawasaki B; Berger B; Austin E; Shea M; Gabrieloff E; Matzinger S; Burdorf A; Nichols J; Goode K; Cilwick A; Stacy C; Staples E; Stringer G
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1084-1087. PubMed ID: 34383734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties - United States, December 14, 2020-April 10, 2021.
    Murthy BP; Sterrett N; Weller D; Zell E; Reynolds L; Toblin RL; Murthy N; Kriss J; Rose C; Cadwell B; Wang A; Ritchey MD; Gibbs-Scharf L; Qualters JR; Shaw L; Brookmeyer KA; Clayton H; Eke P; Adams L; Zajac J; Patel A; Fox K; Williams C; Stokley S; Flores S; Barbour KE; Harris LQ
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(20):759-764. PubMed ID: 34014911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between COVID-19 cases and vaccination rates in New York State counties.
    Cerio H; Schad L; Morley C
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36706247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.
    Taylor CA; Whitaker M; Anglin O; Milucky J; Patel K; Pham H; Chai SJ; Alden NB; Yousey-Hindes K; Anderson EJ; Teno K; Reeg L; Como-Sabetti K; Bleecker M; Barney G; Bennett NM; Billing LM; Sutton M; Talbot HK; McCaffrey K; Havers FP;
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):466-473. PubMed ID: 35324880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study.
    Hernandez I; Dickson S; Tang S; Gabriel N; Berenbrok LA; Guo J
    PLoS Med; 2022 Jul; 19(7):e1004069. PubMed ID: 35901171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Vaccine Initiation and Dose Completion During the SARS-CoV-2 Delta Variant Surge in the United States, December 2020-October 2021.
    Murthy N; Saelee R; Patel Murthy B; Meng L; Shaw L; Gibbs-Scharf L; Harris L; Chorba T; Zell E
    Public Health Rep; 2023; 138(1):183-189. PubMed ID: 36129241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. County-Level COVID-19 Vaccination Coverage and Social Vulnerability - United States, December 14, 2020-March 1, 2021.
    Hughes MM; Wang A; Grossman MK; Pun E; Whiteman A; Deng L; Hallisey E; Sharpe JD; Ussery EN; Stokley S; Musial T; Weller DL; Murthy BP; Reynolds L; Gibbs-Scharf L; Harris L; Ritchey MD; Toblin RL
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(12):431-436. PubMed ID: 33764963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Vaccine Provider Availability and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 1, 2021-April 25, 2022.
    DeCuir J; Meng L; Pan Y; Vogt T; Chatham-Stevens K; Meador S; Shaw L; Black CL; Harris LQ
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(26):847-851. PubMed ID: 35771688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties - United States, December 14, 2020-January 31, 2022.
    Saelee R; Zell E; Murthy BP; Castro-Roman P; Fast H; Meng L; Shaw L; Gibbs-Scharf L; Chorba T; Harris LQ; Murthy N
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):335-340. PubMed ID: 35239636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage.
    Christie A; Brooks JT; Hicks LA; Sauber-Schatz EK; Yoder JS; Honein MA;
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(30):1044-1047. PubMed ID: 34324480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.
    Fabiani M; Puopolo M; Morciano C; Spuri M; Spila Alegiani S; Filia A; D'Ancona F; Del Manso M; Riccardo F; Tallon M; Proietti V; Sacco C; Massari M; Da Cas R; Mateo-Urdiales A; Siddu A; Battilomo S; Bella A; Palamara AT; Popoli P; Brusaferro S; Rezza G; Menniti Ippolito F; Pezzotti P;
    BMJ; 2022 Feb; 376():e069052. PubMed ID: 35144968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study.
    Romero-Brufau S; Chopra A; Ryu AJ; Gel E; Raskar R; Kremers W; Anderson KS; Subramanian J; Krishnamurthy B; Singh A; Pasupathy K; Dong Y; O'Horo JC; Wilson WR; Mitchell O; Kingsley TC
    BMJ; 2021 May; 373():n1087. PubMed ID: 33980718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. County-level vaccination coverage and rates of COVID-19 cases and deaths in the United States: An ecological analysis.
    McLaughlin JM; Khan F; Pugh S; Swerdlow DL; Jodar L
    Lancet Reg Health Am; 2022 May; 9():100191. PubMed ID: 35128511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bias-Adjusted Predictions of County-Level Vaccination Coverage from the COVID-19 Trends and Impact Survey.
    Reitsma MB; Rose S; Reinhart A; Goldhaber-Fiebert JD; Salomon JA
    Med Decis Making; 2024 Feb; 44(2):175-188. PubMed ID: 38159263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Attack Rate and Population Immunity in Southern New England, March 2020 to May 2021.
    Tran TN; Wikle NB; Yang F; Inam H; Leighow S; Gentilesco B; Chan P; Albert E; Strong ER; Pritchard JR; Hanage WP; Hanks EM; Crawford FW; Boni MF
    JAMA Netw Open; 2022 May; 5(5):e2214171. PubMed ID: 35616938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Vaccination Coverage Disparity and the Dynamics of the COVID-19 Delta and Omicron Waves in the US.
    Cuadros DF; Moreno CM; Musuka G; Miller FD; Coule P; MacKinnon NJ
    Front Med (Lausanne); 2022; 9():898101. PubMed ID: 35775002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.